WBWilliam Bolland

William Bolland

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


William Bolland has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The mechanisms and consequences of SARS-CoV-2 induced cell-to-cell fusion

    by William Henry Bolland

    Mécanismes et conséquences de la fusion cellulaire induite par le SARS-CoV-2: Le virus SRAS-CoV-2, l'agent causal de la pandémie COVID-19, est responsable d'environ 7 millions de décès depuis son apparition dans la population humaine à la fin de l'année 2019. Au cours de l'infection, le SRAS-CoV-2 induit la fusion des cellules en cellules multinucléées appelées syncytia. Le rôle des syncytia pendant l'infection par le SRAS-CoV-2 a été caractérisé et comprend la dissémination du virus entre les cellules en évitant la réponse immunitaire humorale de l'hôte. Nous avons montré, avec d'autres, que les différentes variantes du SARS-CoV-2 ont des capacités différentes d'induire la formation de syncytia en raison de mutations dans la protéine virale Spike. Fin 2021, une variante appelée B.1.640.1 a été détectée et s'est répandue en France, entraînant environ 1000 cas au total. En cultivant cette variante, nous avons constaté qu'elle induisait des niveaux très élevés de formation de syncytia. Nous avons donc mené une enquête sur cette variante afin d'étudier l'impact d'une fusogénicité élevée sur la réplication virale et la cytopathie. Pour ce faire, nous avons infecté le virus dans différents modèles pulmonaires, notamment des lignées cellulaires pulmonaires humaines et des épithéliums pulmonaires humains primaires. Après analyse des marqueurs de cytopathie et de réplication, nous avons constaté que cette variante se répliquait de la même manière que la variante Delta dans nos modèles qui ont circulé en même temps que le B.1.640.1. Cependant, ce variant induit des niveaux de cytopathie significativement plus élevés, quantifiés par la libération de LDH de la cellule et la coloration de clivage de la capsase-3. L'analyse mécaniste a révélé que le phénotype hautement fusogène était dû à deux mutations dans le domaine S2 de la protéine Spike. En outre, l'évaluation de la neutralisation du virus par des échantillons de sérum de patients provenant d'hôpitaux a révélé que B.1.640.1 était plus sensible à la vaccination et à l'immunité d'anticorps préexistante provenant d'infections antérieures par le SRAS-CoV-2 que la variante Omicron BA.1. Nous avons donc conclu que le B.1.640.1 a probablement été supplanté par l'émergence du BA.1 à la fin de 2021 et au début de 2022. Les radeaux lipidiques sont des nanodomaines à l'intérieur de la membrane plasmique de la cellule qui sont fortement enrichis en cholestérol et en sphingolipides. Il a été proposé que les radeaux lipidiques agissent comme des plates-formes permettant l'entrée et l'infection de nombreux virus différents en localisant la protéine réceptrice du virus dans les radeaux. Cela a été démontré pour des virus tels que le VHC, le VIH et des coronavirus tels que le SARS-CoV-2. Les études sur le rôle des radeaux lipidiques dans l'infection virale utilisent souvent des agents de déplétion du cholestérol tels que la méthyl-bêta-cyclodextrine pour perturber les radeaux lipidiques et étudier l'impact sur l'entrée du virus. Cependant, l'appauvrissement en cholestérol et la perturbation des radeaux lipidiques peuvent avoir d'autres effets sur la cellule, comme l'altération de la fluidité de la membrane. En outre, le rôle des radeaux lipidiques dans la formation des syncytia du SARS-CoV-2 est actuellement inconnu. Nous avons donc étudié le rôle des radeaux lipidiques sur l'entrée du SARS-CoV-2 et la formation des syncytia par le biais de la localisation de l'ACE2. Nous avons construit une protéine ACE2 ancrée à la GPI, le récepteur du SARS-CoV-2, qui se localise dans les radeaux lipidiques alors que la protéine de type sauvage n'est pas associée aux radeaux. Nous avons ensuite étudié l'impact de la localisation dans les radeaux sur la formation et l'entrée des syncytia du SARS-CoV-2 à l'aide du système GFP-split et de pseudovirus. Nous n'avons trouvé aucune différence dans la formation des syncytia ou l'entrée du SARS-CoV-2. Nous avons ensuite corroboré ces résultats en utilisant le virus authentique.

  • Open Access

    Epitope-Driven Polyfunctional Divergence of SARS-CoV-2 RBD Antibodies

    by Pierre Rosenbaum, Cyril Planchais, Timothée Bruel, Maxime Beretta, Isabelle Staropoli, William-Henry Bolland, Florence Guivel-Benhassine, Delphine Planas, Olivier Schwartz, Hugo Mouquet

    SUMMARY: SARS-CoV-2 antibodies targeting the receptor binding domain (RBD) of the spike protein can potently neutralize infection and exert additional antiviral functions. Here, we characterize the functional profiles of human RBD-specific memory B-cell antibodies elicited by ancestral SARS-CoV-2 infection. While SARS-CoV2 neutralizing antibodies, mainly class 1 and 3 anti-RBD antibodies, often lose binding and neutralizing capacities against Omicron variants, most non-neutralizers remain broadly reactive. Despite their restricted cross-reactivity, neutralizing antibodies mediate Fc-effector functions including antibody-dependent cellular cytotoxicity, phagocytosis, and complement deposition. Most neutralizers also enhance binding of antibodies that target the SARS-CoV-2 spike fusion peptide via receptor-mimetic allostery. In contrast, broadly reactive non-neutralizers fail to trigger phagocytic or allosteric effects. Thus, viral escape compromises antibody neutralizing as well as other antiviral activities, leaving broadly reactive, non-polyfunctional antibodies that exert minimal immune pressure less effective at controlling infection.

  • Open Access

    SARS-CoV-2 entry and fusion are independent of ACE2 localization to lipid rafts

    by William Bolland, Inès Marechal, Chloé Petiot, Françoise Porrot, Florence Guivel-Benhassine, Anne Brelot, Nicoletta Casartelli, Olivier Schwartz, Julian Buchrieser

    Membrane fusion occurs at the early stages of SARS-CoV-2 replication, during entry of the virus, and later during the formation of multinucleated cells called syncytia. Fusion is mediated by the binding of the viral Spike protein to its receptor ACE2. Lipid rafts are dynamic nanodomains enriched in cholesterol and sphingolipids. Rafts can act as platforms for entry of different viruses by localizing virus receptors, and attachment factors to the same membrane domains. Here, we first demonstrate that cholesterol depletion by methyl-beta-cyclodextrin inhibits Spike-mediated fusion and entry. To further study the role of ACE2 lipid raft localization in SARS-CoV-2 fusion and entry, we designed a GPI-anchored ACE2 construct. Both ACE2 and ACE2-GPI proteins were similarly expressed at the plasma membrane. Through membrane flotation assays, we show that in different cell lines, ACE2-GPI localizes predominantly to raft domains of the plasma membrane while ACE2 is non-raft associated. We then compare the ability of ACE2 and ACE2-GPI to permit SARS-CoV-2 entry, replication, and syncytia formation of different viral variants. We find little difference in the two proteins. Our results demonstrate that SARS-CoV-2 entry and fusion are cholesterol-dependent and raft-independent processes. IMPORTANCE: Rafts are often exploited by viruses and used as platforms to enhance their entry into the cell or spread from cell to cell. The membrane localization of ACE2 and the role of lipid rafts in SARS-CoV-2 entry and cell-to-cell spread are poorly understood. The function of lipid rafts in viral fusion is often studied through their disruption by cholesterol-depleting agents. However, this process may have off-target impacts on viral fusion independently of lipid-raft disruption. Therefore, we created an ACE2 construct that localizes to lipid rafts using a GPI anchor. Conversely, wild-type ACE2 was non-raft associated. We find that the localization of ACE2 to lipid rafts does not modify the fusion dynamics of SARS-CoV-2.


  • Open Access

    SARS-CoV-2 entry and fusion are independent of ACE2 localization to lipid rafts

    by William Bolland, Inès Marechal, Chloé Petiot, Françoise Porrot, Florence Guivel-Benhassine, Nicoletta Casartelli, Olivier Schwartz, Julian Buchrieser

    Membrane fusion occurs at the early stages of SARS-CoV-2 replication, during entry of the virus, and later during the formation of multinucleated cells called syncytia. Fusion is mediated by the binding of the viral Spike protein to its receptor ACE2. Lipid rafts are dynamic nanodomains enriched in cholesterol and sphingolipids. Rafts can act as platforms for entry of dìerent viruses by localizing virus receptors, and attachment factors to the same membrane microdomains. Here, we first demonstrate that cholesterol depletion by methyl-beta-cyclodextrin inhibits Spike mediated fusion and entry. To further study the role of ACE2 lipid raft localization in SARS-CoV-2 fusion and entry, we design a GPI-anchored ACE2 construct. Both ACE2 and ACE2-GPI proteins are similarly expressed at the plasma membrane. Through membrane flotation assays, we show that in dìerent cell lines, ACE2-GPI localises predominantly to raft domains of the plasma membrane while ACE2 is non-raft associated. We then compare the ability of ACE2 and ACE2-GPI to permit SARS-CoV-2 pseudovirus entry and syncytia formation and replication of dìerent viral variants. We find little dìerence in the two proteins. Our results demonstrate that SARS-CoV-2 entry and fusion are a cholesterol dependent and raft-independent process. IMPORTANCE Rafts are often exploited by viruses and used as platforms to enhance their entry into the cell or spread from cell-to-cell. The membrane localization of ACE2 and the role of lipid rafts in SARS-CoV-2 entry and cell-to-cell spread is poorly understood. The function of lipid rafts in viral fusion is often studied through their disruption by cholesterol-depleting agents. However, this process may have ò-target impacts on viral fusion independently of lipid-raft disruption. Therefore, we created an ACE2 construct that localizes to lipid rafts using a GPI anchor. Conversely, wild-type ACE2 was non-raft associated. We find that the localization of ACE2 to lipid rafts does not modify the fusion dynamics of SARS-CoV-2.


  • High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1

    by William Bolland, Vincent Michel, Delphine Planas, Mathieu Hubert, Isabelle Staropoli, Florence Guivel-Benhassine, Françoise Porrot, Mélissa N'DEbi, Christophe Rodriguez, Slim Fourati, et al.

    SARS-CoV-2 variants with undetermined properties have emerged intermittently throughout the COVID-19 pandemic. Some variants possess unique phenotypes and mutations which allow further characterization of viral evolution and Spike functions. Around 1,100 cases of the B.1.640.1 variant were reported in Africa and Europe between 2021 and 2022, before the expansion of Omicron. Here, we analyzed the biological properties of a B.1.640.1 isolate and its Spike. Compared to the ancestral Spike, B.1.640.1 carried 14 amino acid substitutions and deletions. B.1.640.1 escaped binding by some anti-N-terminal domain and anti-receptor-binding domain monoclonal antibodies, and neutralization by sera from convalescent and vaccinated individuals. In cell lines, infection generated large syncytia and a high cytopathic effect. In primary airway cells, B.1.640.1 replicated less than Omicron BA.1 and triggered more syncytia and cell death than other variants. The B.1.640.1 Spike was highly fusogenic when expressed alone. This was mediated by two poorly characterized and infrequent mutations located in the Spike S2 domain, T859N and D936H. Altogether, our results highlight the cytopathy of a hyper-fusogenic SARS-CoV-2 variant, supplanted upon the emergence of Omicron BA.1. (This study has been registered at ClinicalTrials.gov under registration no. NCT04750720.) IMPORTANCE: Our results highlight the plasticity of SARS-CoV-2 Spike to generate highly fusogenic and cytopathic strains with the causative mutations being uncharacterized in previous variants. We describe mechanisms regulating the formation of syncytia and the subsequent consequences in a primary culture model, which are poorly understood.


  • Open Access

    High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1

    by William Bolland, Vincent Michel, Delphine Planas, Mathieu Hubert, Florence Guivel-Benhassine, Françoise Porrot, Isabelle Staropoli, Mélissa N’debi, Christophe Rodriguez, Slim Fourati, et al.

    SARS-CoV-2 variants with undetermined properties have emerged intermittently throughout the COVID-19 pandemic. Some variants possess unique phenotypes and mutations which allow further characterization of viral evolution and spike functions. Around 1100 cases of the B.1.640.1 variant were reported in Africa and Europe between 2021 and 2022, before the expansion of Omicron. Here, we analyzed the biological properties of a B.1.640.1 isolate and its spike. Compared to the ancestral spike, B.1.640.1 carried 14 amino acid substitutions and deletions. B.1.640.1 escaped binding by some anti-NTD and -RBD monoclonal antibodies, and neutralization by sera from convalescent and vaccinated individuals. In cell lines, infection generated large syncytia and a high cytopathic effect. In primary airway cells, B.1.640.1 replicated less than Omicron BA.1 and triggered more syncytia and cell death than other variants. The B.1.640.1 spike was highly fusogenic when expressed alone. This was mediated by two poorly characterized and infrequent mutations located in the spike S2 domain, T859N and D936H. Altogether, our results highlight the cytopathy of a hyper-fusogenic SARS-CoV-2 variant, supplanted upon the emergence of Omicron BA.1. Importance Our results highlight the plasticity of SARS-CoV-2 spike to generate highly fusogenic and cytopathic strains with the causative mutations being uncharacterized in previous variants. We describe mechanisms regulating the formation of syncytia and the subsequent consequences in cell lines and a primary culture model, which are poorly understood.